In a latest note to investors, a research analyst has provided a rating update for the Healthcare company, Jamieson Wellness Inc (JWEL). Yesterday, analyst George Doumet gave a Buy rating to JWEL and set a C$22 price target.
According to TipRanks.com, Doumet is ranked #1851 out of 5188 analysts.
Read also: Tilray (TLRY) Ramping up Cannabis Supply in Canada with Acquisition of Natura Naturals Holdings
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Jamieson Wellness Inc with a C$22.50 average price target.
The company has a one-year high of C$27.88 and a one-year low of C$17.15. Currently, Jamieson Wellness Inc has an average volume of 79.97K.
Jamieson Wellness, Inc. engages in the manufacture and sale of sports nutrition products and specialty supplements. It operates through the Jamieson Brands and Strategic Partners segments. The Jamieson Brands segment comprises manufacture, distribution, and marketing of branded natural health products including vitamins, minerals, and supplements.
The company’s shares closed on Wednesday at C$17.99, close to its 52-week low of C$17.15.
